Zhonghong Pulin Medical Products Co. Ltd. - Asset Resilience Ratio

Latest as of June 2026: 34.68%

Zhonghong Pulin Medical Products Co. Ltd. (300981) has an Asset Resilience Ratio of 34.68% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhonghong Pulin Medical Products Co. Ltd (300981) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥2.67 Billion
≈ $390.20 Million USD Cash + Short-term Investments

Total Assets

CN¥7.69 Billion
≈ $1.13 Billion USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Zhonghong Pulin Medical Products Co. Ltd.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300981 total asset value.

Liquid Assets Composition Over Time

This chart breaks down Zhonghong Pulin Medical Products Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Zhonghong Pulin Medical Products Co. Ltd (300981) financial obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥2.67 Billion 34.68%
Total Liquid Assets CN¥2.67 Billion 34.68%

Asset Resilience Insights

  • Very High Liquidity: Zhonghong Pulin Medical Products Co. Ltd. maintains exceptional liquid asset reserves at 34.68% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Zhonghong Pulin Medical Products Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Zhonghong Pulin Medical Products Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Eyebright Medical Technology Beijing Co Ltd
SHG:688050
Medical Instruments & Supplies 1.51%
Andon Health Co Ltd
SHE:002432
Medical Instruments & Supplies 18.11%
Vizionfocus Inc.
TW:4771
Medical Instruments & Supplies 3.24%
Pro-Dex Inc
NASDAQ:PDEX
Medical Instruments & Supplies 1.39%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%
Mark Dynamics Indonesia Tbk PT
JK:MARK
Medical Instruments & Supplies 6.64%
Interojo Inc
KQ:119610
Medical Instruments & Supplies 6.55%

Annual Asset Resilience Ratio for Zhonghong Pulin Medical Products Co. Ltd. (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Zhonghong Pulin Medical Products Co. Ltd..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 25.29% CN¥1.88 Billion
≈ $275.30 Million
CN¥7.44 Billion
≈ $1.09 Billion
+1.40pp
2024-12-31 23.89% CN¥1.73 Billion
≈ $252.78 Million
CN¥7.23 Billion
≈ $1.06 Billion
-8.13pp
2023-12-31 32.03% CN¥2.26 Billion
≈ $330.71 Million
CN¥7.06 Billion
≈ $1.03 Billion
-5.27pp
2022-12-31 37.29% CN¥2.54 Billion
≈ $371.99 Million
CN¥6.82 Billion
≈ $997.49 Million
-12.55pp
2021-12-31 49.84% CN¥3.56 Billion
≈ $521.62 Million
CN¥7.15 Billion
≈ $1.05 Billion
+39.43pp
2020-12-31 10.41% CN¥382.43 Million
≈ $55.96 Million
CN¥3.67 Billion
≈ $537.43 Million
--
pp = percentage points

About Zhonghong Pulin Medical Products Co. Ltd.

SHE:300981 China Medical Instruments & Supplies
Market Cap
$1.14 Billion
CN¥7.78 Billion CNY
Market Cap Rank
#8368 Global
#1958 in China
Share Price
CN¥18.15
Change (1 day)
+14.01%
52-Week Range
CN¥9.50 - CN¥18.15
All Time High
CN¥47.82
About

Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health protection products, sterile medical devices, and life support solutions in China and internationally. It operates through the Health Protection Products Division; Safe Infusion Products Division; and Innovation and Incubation Product Division… Read more